Monday 22 April 2024
 
»
 
»
Story

Celularity seals distribution agreement with AD Ports Group

RIYADH, March 28, 2023

Celularity, a biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, has announced that it has entered into an exclusive distribution agreement with AD Ports Logistics (ADPL), a subsidiary of AD Ports Group, the leading global facilitator of trade, logistics and industry based in Abu Dhabi.
 
In partnership with CH Trading Group, an international import, export and trading company, ADPL will distribute the Celularity’s biomaterial products in the UAE, Qatar, Bahrain, Oman, Kuwait and Egypt, said the company in a statement.
 
Farook Al Zeer, Chairman, Logistics Cluster, AD Ports Group, said: "We are pleased to work with Celularity to expand access to these innovative products within the UAE and the region by leveraging our advanced GDP-certified pharma logistics network and the unique capabilities of our Healthcare & Life Sciences Team."
 
"Becoming the distributor of choice for Celularity’s biomaterial products is yet another example of how we are working with our industry partners to ensure that our communities across the nation can receive access to the best and most innovative healthcare products possible. We believe that collaborative partnerships such as these will play a significant role in helping deliver on our leadership’s vision of establishing Abu Dhabi as a hub for global healthcare and life science excellence," he noted.
 
Celularity CEO, Chairman and Founder, Robert J. Hariri said today’s announcement highlights a significant milestone in the group's global expansion strategy and focus on the Middle East and North Africa market.
 
According to the most recent analysis by Emergent Research, the worldwide regenerative medicine market was $9.8 billion in 2021 and is anticipated to grow at a revenue CAGR of 15.9% to reach $37.10 billion in 2030.
 
"In consultation with our distributors, we look forward to extending the reach of Celularity’s commercial biomaterial products to more people in the Middle East over the next decade,” said CH Trading Group CEO, Sayed Zayan. 
 
"We are excited to partner with Celularity and AD Ports Group on increasing access to innovative health and wellness solutions for patients in the GCC region and beyond – and the expanding market for Celularity’s Halal-Certified biomaterial products," he added.-TradeArabia News Service



Tags:

More Industry, Logistics & Shipping Stories

calendarCalendar of Events

Ads